|
|
Alternate Title Women's Intervention Nutrition Study (WINS): Randomized Study to Determine the Efficacy of Dietary Fat Reduction in Addition to Conventional Systemic Adjuvant Therapy in Postmenopausal Women Surgically Treated for Primary Invasive Breast Cancer
Trial Description Dietary fat may be involved in the growth of cancer cells. Restricting dietary fat may help fight cancer. Randomized clinical trial to study the effectiveness of a low fat diet in treating postmenopausal women who have stage I, stage II, or stage IIIA breast cancer that has been completely removed by surgery.
Final eligibility for a clinical trial is determined by the health professionals conducting the trial. Patients will be randomly assigned to one of two groups. During individual and group counseling sessions, patients in group one will receive detailed instructions for following a low fat diet. Patients in group two will receive dietary guidelines with minimal counseling. All patients will receive follow-up evaluations once a year during the study. Important: For more details about this trial, refer to the Health Professional version of the trial summary. If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site. Trial Lead Organizations Institute for Cancer Prevention
Back to Top |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NCI Home |
Text-Only Version |
Contact Us |
Policies |
Accessibility |
RSS |
Viewing Files |
FOIA |
Site Help |
Site Map
|
A Service of the National Cancer Institute |